- Home
- HQL vs LFMD Comparison
HQL vs LFMD Comparison
Compare HQL & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQL
- LFMD
- Stock Information
- Founded
- HQL 1992
- LFMD 1994
- Country
- HQL United States
- LFMD United States
- Employees
- HQL N/A
- LFMD N/A
- Industry
- HQL Investment Managers
- LFMD Medical/Nursing Services
- Sector
- HQL Finance
- LFMD Health Care
- Exchange
- HQL Nasdaq
- LFMD Nasdaq
- Market Cap
- HQL 368.7M
- LFMD 306.7M
- IPO Year
- HQL N/A
- LFMD N/A
- Fundamental
- Price
- HQL $12.87
- LFMD $5.45
- Analyst Decision
- HQL
- LFMD Strong Buy
- Analyst Count
- HQL 0
- LFMD 7
- Target Price
- HQL N/A
- LFMD $11.57
- AVG Volume (30 Days)
- HQL 120.9K
- LFMD 1.6M
- Earning Date
- HQL 01-01-0001
- LFMD 03-10-2025
- Dividend Yield
- HQL 11.56%
- LFMD N/A
- EPS Growth
- HQL N/A
- LFMD N/A
- EPS
- HQL 0.79
- LFMD N/A
- Revenue
- HQL N/A
- LFMD $212,453,838.00
- Revenue This Year
- HQL N/A
- LFMD $23.50
- Revenue Next Year
- HQL N/A
- LFMD $17.20
- P/E Ratio
- HQL $17.08
- LFMD N/A
- Revenue Growth
- HQL N/A
- LFMD 39.27
- 52 Week Low
- HQL $11.34
- LFMD $3.99
- 52 Week High
- HQL $14.37
- LFMD $12.88
- Technical
- Relative Strength Index (RSI)
- HQL 40.00
- LFMD 46.74
- Support Level
- HQL $12.90
- LFMD $5.47
- Resistance Level
- HQL $13.30
- LFMD $6.15
- Average True Range (ATR)
- HQL 0.20
- LFMD 0.45
- MACD
- HQL 0.02
- LFMD 0.03
- Stochastic Oscillator
- HQL 42.62
- LFMD 32.69
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.